2016 Report details for project: Electronic Prescription Service (EPS) Release 2

Project name: Electronic Prescription Service (EPS) Release 2 - there are 5 reports for this project: 2013, 2014, 2015, 2016, 2017
Google search: Google search on project name (opens in new window) opens in new window
Organisation: DOH (D12) - see all reports for this organisation
Report year: 2016 (data is from Sept 2015)
Category: ICT - see all reports for this category
Description: The Electronic Prescription Service enables prescribers - such as GPs and practice nurses - to send prescriptions electronically to a dispenser (such as a pharmacy) of the patient's choice. This makes the prescribing and dispensing process more efficient and convenient for patients and staff.
DCA (RAG): Amber
DCA text: The rating was confirmed by the outcome of the Major Projects Authority Gate 5a review in December 2015. Recommendations, which cover the top risks (A need for more robust planning, a clearer timeline and dependencies for the prerequisites, including Controlled Drugs and Business Continuity), were made to aid the programme in progressing towards successful implementation of Phase 4. An action plan to achieve review recommendations was worked up in January 2016 and work continues following approval of a Tolerance Exception Report, which sought funding to deliver the revised full scope including pre-requisites for Phase 4. Release 2 contains both phase 3 and phase 4, which will allow all prescriptions to be sent electronically without requiring a patient nomination. Progress has also been made on Completion of Service Model Review - for which development of the implementation plan is now underway; updating and agreeing Terms of Reference for the Programme Board; and putting a benefits realisation strategy, methodology and associated data gathering processes in place. As of November 2015, 5,556 GP Practices had deployed technology for the Electronic Prescription Service. This brings deployment up to 73.1%. Estimated prescription claims made using the Electronic Prescription Service in October 2015 was 34.8% - ahead of a forecast of 29% and a year-end target of 33%.
Start date: 2003-01-01
End date: 2016-12-31
Schedule text: The rollout of EPS Release 2 to prescribing sites had been slower than anticipated and the BSA redundancies were not realised. It was expected that EPS Release 2 would be rolled out to 100% of prescribing and dispensing sites by the end of December 2009. In reality, as of December 2013, 91% of dispensing sites (pharmacies) and 16% of prescribing sites (GP practices) had EPS Release 2 deployed, and this increased to 98.2% of dispensing sites and 65.8% of prescribing sites as of September 2015. The factors which led to the lower than expected national rollout of EPS Release 2 were fully explored and documented in the Extension Business Case.
Baseline: £4.96m
Forecast: £7.83m
Variance: 57.86%
Variance text: The increase in budget for 2015/16 is due to the approved change request for the Phase 4 pre-requisites, including Pharmacy Training, Business Continuity and Controlled Drugs, which is additional activity, covered in the Tolerance Exception Report/Change Request.
Whole Life Cost: £77.73m
WLCost text: There is now a significant reduction in forecast costs compared to budget because the rollout of Electronic Prescription Service Release 2 to prescribing sites was slower than anticipated and NHS Business Sservice Authority redundancies, which had been budgeted for centrally, will not now take place.
Notes1:
Notes2:
Sourcefile: IPA_2016.csv

Home Selection Search All Reports All Projects (+dates) All Projects (+costs) All Organisations All Years All Categories


Acknowledgement: GMPP data has been re-used under the Open Government Licence.